These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 3044793

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH.
    N Engl J Med; 1986 Jun 12; 314(24):1547-52. PubMed ID: 3520315
    [Abstract] [Full Text] [Related]

  • 3. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Loeb HS, Johnson G, Henrick A, Smith R, Wilson J, Cremo R, Cohn JN.
    Circulation; 1993 Jun 12; 87(6 Suppl):VI78-87. PubMed ID: 8500244
    [Abstract] [Full Text] [Related]

  • 4. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN, Archibald DG, Francis GS, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Flohr KH.
    Circulation; 1987 May 12; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [Abstract] [Full Text] [Related]

  • 5. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Ziesche S, Cobb FR, Cohn JN, Johnson G, Tristani F.
    Circulation; 1993 Jun 12; 87(6 Suppl):VI56-64. PubMed ID: 8500241
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Cintron G, Johnson G, Francis G, Cobb F, Cohn JN.
    Circulation; 1993 Jun 12; 87(6 Suppl):VI17-23. PubMed ID: 8500235
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A.
    Circulation; 1993 Jun 12; 87(6 Suppl):VI40-8. PubMed ID: 8500238
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lessons from V-HeFT: questions for V-HeFT II and the future therapy of heart failure.
    Cohn JN.
    Herz; 1991 Sep 12; 16 Spec No 1():267-71. PubMed ID: 1820292
    [Abstract] [Full Text] [Related]

  • 16. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
    Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN.
    Circulation; 1993 Jun 12; 87(6 Suppl):VI102-10. PubMed ID: 8500233
    [Abstract] [Full Text] [Related]

  • 17. Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate.
    Adigun AQ, Ajayi OE, Sofowora GG, Ajayi AA.
    Int J Cardiol; 1998 Nov 30; 67(1):81-6. PubMed ID: 9880204
    [Abstract] [Full Text] [Related]

  • 18. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group.
    Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, Smith R, Fletcher R.
    Circulation; 1993 Jun 30; 87(6 Suppl):VI5-16. PubMed ID: 8500240
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.